[ET Net News Agency, 10 March 2026] SKB BIO-B (06990) rose 9.3% to HK$415.2.
It hits an intra-day high of HK$418, breaking above the 250-D SMA of HK$394.217, and an
intra-day low of HK$394.8. The total shares traded was 204,447, with a value of HK$83.35m.
The active buy/sell ratio is 73:27, with net buying turnover of HK$33.85m. CLSA LTD
accounts for greatest net responsive buying turnover of HK$4.97m, with volume weighted
average price of HK$407.403. J.P. MORGAN BRO (HK) accounts for greatest net responsive
selling turnover of HK$15.39m, with volume weighted average price of HK$407.784.

Basic Information
=================

-----------------------------------
Nominal 415.200 % Chg +9.26%
High 418.000 Low 394.800
Shares Tr 204,447 Turnover 83.35m
10-D SMA 379.700 %H.V 47.899
20-D SMA 400.420 VWAP 407.678
50-D SMA 420.112 RSI14 54.455
-----------------------------------
Status: Breaking above the 250-D SMA, active buy/sell ratio is 73:27, with net buying
turnover of HK$33.85m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
SKB BIO-B (06990) 415.20 +9.26
INNOVENT BIO (01801) 84.95 +3.91
CARSGEN-B (02171) 15.02 +7.90
XTALPI (02228) 9.99 +2.57
WUXI BIO (02269) 36.48 +2.99
WUXI APPTEC (02359) 111.60 +2.57
TRANSTHERA-B (02617) 86.60 +1.23
BEONE MEDICINES (06160) 183.90 +2.79
AKESO (09926) 112.10 +8.10
REMEGEN (09995) 87.65 +2.69
-----------------------------------------------
(ed)